RExPO25

About RExPO25

The fourth installment in the RExPO series

The REPO4EU Horizon Europe project currently building a European/Global Platform and Infrastructure for Drug Repurposing hosted its 4th International Conference on Systems Medicine, Artificial Intelligence and Drug Repurposing in Barcelona, Spain, from September 24-26, 2025.

CHECK OUR PHOTO GALLERY

120+

ATTENDEES

65+

SPEAKERS

13

POSTERS IN SHOW

65

PUBLICATIONS

The collection

Our ScienceOpen repository

All selected abstracts and presentations for RExPO25 have been published under a unique DOI at our online collection on ScienceOpen, as part of the conference’s proceedings – make sure to check out the full collection at the link below!

BROWSE THE CONFERENCE PROCEEDINGS

Network medicine

Network pharmacology

Precision diagnostics

Innovative trials

AI, LLMs & the EHDS

Drug reformulation

Patient-centered care

Implementation in healthcare

HTA reimbursement & payers

IP - Patenting or charity?

Regulatory science

Global impact & the UN Agenda 2030


RExPO26

Save the date

Join us this September 23–25 in Berlin for the fifth edition of RExPO, Europe’s leading conference in the intersection of systems medicine, network pharmacology, Artificial Intelligence and drug repurposing.

RExPO26 brings together clinicians, researchers, industry leaders, SMEs, patient organizations, regulators, payers and policymakers to shape the next generation of mechanism-based precision therapeutics.

Choose your spot

EARLY BIRD PRICES

Registration will open soon – stay tuned!

GENERAL ADMISSION

FULL PASS

400 EUR

GENERAL ADMISSION

2-DAY PASS

360 EUR

GENERAL ADMISSION

DAY PASS (LIMITED)

210 EUR

START-UPS

FULL PASS

300 EUR

START-UPS

2-DAY PASS

260 EUR

START-UPS

DAY PASS (LIMITED)

150 EUR

ACADEMIA

FULL PASS

250 EUR

ACADEMIA

2-DAY PASS

210 EUR

ACADEMIA

DAY PASS (LIMITED)

130 EUR

PHD STUDENTS

FULL PASS

150 EUR

PHD STUDENTS

2-DAY PASS

130 EUR

PHD STUDENTS

DAY PASS (LIMITED)

90 EUR

PATIENTS & PATIENT ORGANISATIONS

FULL PASS

75 EUR

PATIENTS & PATIENT ORGANISATIONS

2-DAY PASS

65 EUR

PATIENTS & PATIENT ORGANISATIONS

DAY PASS (LIMITED)

40 EUR

Conference tracks

Unmet medical needs in cancer

Unmet medical needs in neurological diseases

The REMEDi4ALL sister project

Innovation in drug development & repurposing

Network medicine approaches to adverse drug event prediction for new & repurposed drugs

Translating to the global market

AI/ML in systems medicine & drug repurposing

Fostering mechanism-based repurposing around the globe

REPO4EU's drug repurposing platform

The last mile: accessibility for patient benefit

Computational drug repurposing

The role of IP in the drug repurposing business case

The patients' voice and patient-centricity

What are you waiting for?

Meet a vibrant community of researchers, clinicians and innovators that are redefining precision medicine from mechanism to patient impact.

OUR SPEAKERS

Our call for abstracts is now open

If your abstract is selected, you’ll have the chance to present your work either during our dedicated Poster Sessions or as one of the conference’s Main Talks.

KEY TOPICS

REPO4EU's drug repurposing platform

Don't miss the official launch of our platform's beta version, first live presentation and hands-on demonstration.

LEARN MORE

The EU drug repurposing ecosystem

Meet all the major initiatives in drug repurposing (including REPO4EU, REMEDi4ALL and RePo-SUDOE) in one place.

LEARN MORE

Rare diseases & precision therapeutics

New translational strategies for rare and ultra-rare diseases, from mechanism discovery to targeted intervention.

LEARN MORE

The Network Medicine Alliance

Systems-level approaches to disease mechanisms, patient stratification and therapeutic innovation, plus a keynote lecture by Joseph Loscalzo, one of the founding figures of Network Medicine.

LEARN MORE

Generative AI & real-world applications

Gen AI use cases in systems medicine, biomarker discovery, hypothesis generation and clinical decision support.

LEARN MORE

Clinical trial validation & PoC studies

First validation results from REPO4EU-associated clinical studies and translational pilots.

LEARN MORE

Open Science, publishing & data sharing

New models for transparent science, FAIR data and dissemination in biomedical publishing.

LEARN MORE

IP strategy, reimbursement & sustainable market access

From intellectual property frameworks to payer acceptance, pricing and long-term implementation.

LEARN MORE

Useful information for attendees

Where will the conference take place?

RExPO26 will be held at Futurium. The venue’s full address is: Alexanderufer 2, 10117 Berlin, Germany.

Check it out

How do I get in touch?

For any topic related to RExPO26, please feel free to contact the conference office. We will be happy to help – you can reach us directly via email.

Contact us

000 days 00 hours 00 minutes 00 seconds

UNTIL RExPO26

In collaboration with...

Our Platinum Sponsor

Buchanan’s Life Sciences Industry Group offers a rare and comprehensive mix of FDA Regulatory, Intellectual Property, Litigation and Government Relations services delivered through one seamless team. They counsel clients on the full range of issues that arise during the product lifecycle, from idea conception to commercialization. Their clients, which include leading pharmaceutical companies, biotechnology companies, wholesalers and distributors, retailers, industry trade associations and leading research institutions, trust Buchanan Life Sciences with their most challenging business and legal problems.


RExPO24

About RExPO24

The third installment in the RExPO series

The REPO4EU Horizon Europe project currently building a European/Global Platform and Infrastructure for Drug Repurposing hosted its 3rd International Conference on Systems Medicine, Artificial Intelligence and Drug Repurposing in Munich, Germany, from July 3-5, 2024.

110+

ATTENDEES

40+

SPEAKERS

10

POSTERS IN SHOW

52

PUBLICATIONS

The collection

Our ScienceOpen repository

All selected abstracts and presentations for RExPO24 have been published under a unique DOI at our online collection on ScienceOpen, as part of the conference’s proceedings – make sure to check out the full collection at the link below!

BROWSE THE CONFERENCE PROCEEDINGS

Network medicine

Network pharmacology

Precision diagnostics

Innovative trials

AI, LLMs & the EHDS

Drug reformulation

Patient-centered care

Implementation in healthcare

HTA reimbursement & payers

IP - Patenting or charity?

Regulatory science

Global impact & the UN Agenda 2030


RExPO23

About RExPO23

The second installment in the RExPO series

The REPO4EU Horizon Europe project currently building a European/Global Platform and Infrastructure for Drug Repurposing hosted its 2nd International Conference on Systems Medicine, Artificial Intelligence and Drug Repurposing in Stockholm, Sweden, from October 25-26, 2023.

115+

ATTENDEES

45+

SPEAKERS

8

POSTERS IN SHOW

51

PUBLICATIONS

The collection

Our ScienceOpen repository

All selected abstracts and presentations for RExPO23 have been published under a unique DOI at our online collection on ScienceOpen, as part of the conference’s proceedings – make sure to check out the full collection at the link below!

BROWSE THE CONFERENCE PROCEEDINGS

Network medicine

Network pharmacology

Precision diagnostics

Innovative trials

AI, LLMs & the EHDS

Drug reformulation

Patient-centered care

Implementation in healthcare

HTA reimbursement & payers

IP - Patenting or charity?

Regulatory science

Global impact & the UN Agenda 2030


RExPO Conference Series

The International Conference Series onSystems Medicine, AI & Drug Repurposing

Welcome to the drug repurposing revolution

Networking has always been the prime focus of any scientific and business event. RExPO is both, high impact science and innovative business. We have multiple collaborations around the world who pool together their knowledge and know-how to deliver the best possible outcome in the single major opportunity in drug development, i.e., drug repurposing. REPO4EU has partnered with professional societies, companies, patent attorneys, legal and ethics experts, clinical research organisations, regulators, payers, patient representatives and many more.

The RExPO conference is a one-of-a-kind opportunity to rank up knowledge and build up collaborations, creating, nurturing and expanding alliances in drug repurposing with world-class experts in the field.

UPCOMING

September 23-25, 2026

Futurium
Berlin, Germany

LEARN MORE

RExPO22

About RExPO22

Welcome to the drug repurposing revolution

The REPO4EU Horizon Europe project currently building a European/Global Platform and Infrastructure for Drug Repurposing officially kicked-off with the first International Conference on Systems Medicine, Artificial Intelligence and Drug Repurposing in Maastricht, The Netherlands, from September 2-3, 2022.

120+

ATTENDEES

40+

SPEAKERS

11

POSTERS IN SHOW

42

PUBLICATIONS

The collection

Our ScienceOpen repository

All selected abstracts and presentations for RExPO22 have been published under a unique DOI at our online collection on ScienceOpen, as part of the conference’s proceedings – make sure to check out the full collection at the link below!

BROWSE THE CONFERENCE PROCEEDINGS

Network medicine

Network pharmacology

Precision diagnostics

Innovative trials

AI, LLMs & the EHDS

Drug reformulation

Patient-centered care

Implementation in healthcare

HTA reimbursement & payers

IP - Patenting or charity?

Regulatory science

Global impact & the UN Agenda 2030


RExPO26 Abstracts

Want to showcase your work at RExPO26?

Submit your Abstract

RExPO26 will be a one-of-a-kind opportunity to rank up knowledge and build up collaborations. Come share your work with us and get the chance to interact with other experts on drug repurposing!

The agenda for RExPO26 is nearly final, with just a few slots open for late-breaking hot topics and posters.
Last chance to submit your abstract!

IN THE SPOTLIGHT

If your abstract is selected by our editorial committee, you’ll have the chance to participate in either our Main Talks or dedicated Poster Sessions.

OFFICIAL PUBLICATIONS

All selected abstracts and presentations will be published under a unique DOI in the RExPO26 online collection on the Drug Repurposing Central portal.

Learn how

OUR ABSTRACT GUIDELINES

All submissions will be carried out through our platform at ScienceOpen. Read on to learn how you can submit your abstract – all proposals will be considered for our dedicated Poster Sessions and some will be selected to be featured as Main Talks.

Only registered users can submit – make sure you are logged in before starting the submission process!

STEP 1

PREPARE YOUR SUBMISSION

Shape your conference submission according to the conference key topics. You’ll need to provide a brief abstract, keywords and references for your proposal.

STEP 2

START THE SUBMISSION PROCESS

Once your abstract is ready, follow the link below to our submission platform on Drug Repurposing Central. Click on the button in the header labeled “Submit your conference proceedings” to navigate to the submission form. Fill in all the required fields. Don’t forget to include the ORCID IDs of your co-authors, ROR IDs for affiliations and grant IDs and numbers.

GO TO DRUG REPURPOSING CENTRAL

STEP 3

YOUR ABSTRACT IS UNDER REVIEW

Abstracts will be carefully reviewed by our editorial team. Some of them may be selected as Main Talks for RExPO26 and added to our final agenda. All others will be showcased during our dedicated Poster Sessions.

STEP 4

GET READY FOR RExPO26

If your abstract is accepted, congratulations! The organizing committee will reach out to you to give you all the necessary details to make your RExPO26 experience a success!

THE RULES

Presenting authors for selected talks and/or posters are required to attend the conference in person and be available in time for the scheduled slot allocated to their talk and/or poster presentation.

Authors agree that their personal data (name and email address) will be temporarily stored, processed and used for the purpose of organizing the conference and managing poster abstract submissions. Personal data will be promptly deleted after the conference. Authors have the right to object to such use or processing of personal data at any time, by emailing their objection to rexpo@repo4.eu

THE TIMELINE

The deadline to submit your abstract is June 30, 2026

Please note: late submissions received after the deadline may be considered, but only if the topics proposed in the abstract are perceived as highly valuable towards the conference.

000 days 00 hours 00 minutes 00 seconds

UNTIL RExPO26